Latest filing published 30 Dec 2020 for Tracon Pharmaceuticals, Inc., €4.1M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ikarian Capital, LLC: trading record in brief
Ikarian Capital, LLC is a declared insider of Tracon Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 12 filings; the first trade dates from 4 September 2020 and the latest from 30 December 2020.
On the market, this insider has only ever bought: 12 purchases, €6.0M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
In size, the median ticket on the buying side is €235k. Of 8 purchases, 8 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 30 December 2020: an open-market purchase of €4.1M, in Tracon Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 8 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ikarian Capital, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 520,291 shares@ US$9.6179.7% of flowCommon Stock, par value $0.001 per shareSEC:0000899243-20-035537:0Canonical exit: 30 Mar 2021 (T+90)
- 7,700 shares@ US$4.77060.6% of flowCommon Stock, par value $0.001 per shareSEC:0000899243-20-030865:0Canonical exit: 27 Jan 2021 (T+90)
- 21,300 shares@ US$4.64351.7% of flowCommon Stock, par value $0.001 per shareSEC:0000899243-20-030865:1Canonical exit: 28 Jan 2021 (T+90)
- 5,000 shares@ US$7.52580.6% of flowCommon Stock, par value $0.001 per shareSEC:0000899243-20-030865:2Canonical exit: 9 Feb 2021 (T+90)
- 151,611 shares@ US$2.86597.2% of flowCommon Stock, par value $0.001 per shareSEC:0000899243-20-025195:0Canonical exit: 3 Dec 2020 (T+90)
- 13,244 shares@ US$2.900.6% of flowCommon Stock, par value $0.001 per shareSEC:0000899243-20-025195:1Canonical exit: 7 Dec 2020 (T+90)
- 79,415 shares@ US$3.49384.6% of flowCommon Stock, par value $0.001 per shareSEC:0000899243-20-025195:2Canonical exit: 8 Dec 2020 (T+90)
- 78,201 shares@ US$3.9265.1% of flowCommon Stock, par value $0.001 per shareSEC:0000899243-20-025195:3Canonical exit: 10 Dec 2020 (T+90)
8 of 8 declarations
